Immunotherapy is changing the cancer landscape

We are embarking on a new horizon in fighting cancer, and it looks like there's a possibility we might win this battle. Cancer treatment and patients' prognosis are changing in positive ways, in part, due to the introduction of immunotherapy.

Read more.

By WVCI


View all posts by WVCI
Posted February 21, 2017

CATEGORY

TAGS

Forum offers information for navigating work with breast cancer

Susan G. Komen Oregon & SW Washington is hosting a forum on Sat., Oct. 22 at the Eugene Hilton on how to navigate a cancer diagnosis and employment from a survivor's and business/human resources perspective.

This forum is for breast cancer patients, employers, and human resources specialists. 

Read more.

By WVCI


Posted October 11, 2016

What is a clinical trial?

Clinical trials are the centerpiece for the drug-testing system in the United States.

Each cancer study conducted tries to answer scientific questions and determine better ways to prevent, diagnose or treat the disease. As researchers test the effectiveness of trial drugs, patients who participate, in many cases, benefit from life-saving treatment options years before they are available to the public.

As a member of The US Oncology Network, Willamette Valley Cancer Institute and Research Center offers patients access to one of the nation’s largest research networks.

“Historically, the perspective has been that in order to get the latest, greatest, most innovative care, someone has to go to a university,” says Dr. Jeff Sharman, Medical Director of Hematology for The US Oncology Network. “WVCI’s unique affiliation with The US Oncology Network enables us to bring trials to patients in Eugene.”

Read more.

By WVCI


Posted August 24, 2015

Do your skin a favor, don’t forget sunscreen

With skin cancer being the most common of all cancers, protecting yourself from the sun is something to think about all year long, especially on these hot, summer days.

Read more.

By WVCI


View all posts by WVCI
Posted July 8, 2015

“Jolie Effect” continuing to raise awareness

No matter what you think of Angelina Jolie Pitt, when she talks, people listen.

That's certainly been the case since 2013 when the actress revealed in The New York Times that she is a carrier of the BRCA1 gene mutation, which fueled her decision to have a preventative double mastectomy.

Read more.

by WVCI


View all posts by WVCI
Posted April 7, 2015